Abstract:The nuclear factor κ enhancer binding protein (NF-κB) signalling pathway is important for a range of cellular processes including immune function. Here Xia et al. show that free Lys63 polyubiquitin chains generated, which are not linked to any protein substrates, can directly activate kinases in the NK- κB signalling pathway. Disassembly of the polyubiquitin chains by deubiquitination enzymes prevented kinase activation. These results suggest that unanchored polyubiquitin chains much like second messengers can directly activate kinases in immune and inflammatory pathways. The ubiquitin ligase TRAF6 is essential for the activation of NF-κB and MAP kinases in several signalling pathways important for a range of cellular processes including immune function. TRAF6 functions together with a ubiquitin-conjugating enzyme complex to activate the TAK1 kinase complex downstream, which in turn leads to the activation of NF-κB. Here, by reconstituting TAK1 activation in vitro, free Lys 63 polyubiquitin chains are shown to activate TAK1 directly. TRAF6 is a ubiquitin ligase that is essential for the activation of NF-κB and MAP kinases in several signalling pathways, including those emanating from the interleukin 1 and Toll-like receptors1,2,3. TRAF6 functions together with a ubiquitin-conjugating enzyme complex consisting of UBC13 (also known as UBE2N) and UEV1A (UBE2V1) to catalyse Lys 63-linked polyubiquitination, which activates the TAK1 (also known as MAP3K7) kinase complex4,5. TAK1 in turn phosphorylates and activates IκB kinase (IKK), leading to the activation of NF-κB. Although several proteins are known to be polyubiquitinated in the IL1R and Toll-like receptor pathways, it is not clear whether ubiquitination of any of these proteins is important for TAK1 or IKK activation. By reconstituting TAK1 activation in vitro using purified proteins, here we show that free Lys 63 polyubiquitin chains, which are not conjugated to any target protein, directly activate TAK1 by binding to the ubiquitin receptor TAB2 (also known as MAP3K7IP2). This binding leads to autophosphorylation and activation of TAK1. Furthermore, we found that unanchored polyubiquitin chains synthesized by TRAF6 and UBCH5C (also known as UBE2D3) activate the IKK complex. Disassembly of the polyubiquitin chains by deubiquitination enzymes prevented TAK1 and IKK activation. These results indicate that unanchored polyubiquitin chains directly activate TAK1 and IKK, suggesting a new mechanism of protein kinase regulation.

Interleukin-1 (Il-1)-induced TAK1-dependent Versus MEKK3-dependent NFκB Activation Pathways Bifurcate at IL-1 Receptor-associated Kinase Modification

IRAK-M Mediates Toll-like Receptor/il-1R-induced NFκB Activation and Cytokine Production

IL-1-induced NFκB and c-Jun N-terminal kinase (JNK) activation diverge at IL-1 receptor-associated kinase (IRAK)

Il-1-Induced Nf Kappa B and C-Jun N-Terminal Kinase (jnk) Activation Diverge at Il-1 Receptor-Associated Kinase (Irak)

TLR8-mediated NF-κB and JNK Activation Are TAK1-independent and MEKK3-dependent

Interleukin-1 (IL-1) Receptor-Associated Kinase-Dependent IL-1-Induced Signaling Complexes Phosphorylate TAK1 and TAB2 at the Plasma Membrane and Activate TAK1 in the Cytosol

The Dual Functions of IL-1 Receptor-Associated Kinase 2 in TLR9-Mediated IFN and Proinflammatory Cytokine Production

Β-Trcp-mediated IRAK1 Degradation Releases TAK1-TRAF6 from the Membrane to the Cytosol for TAK1-Dependent NF-κB Activation

Phosphorylation of Thr-178 and Thr-184 in the TAK1 T-loop is Required for Interleukin (Il)-1-mediated Optimal NFκB and AP-1 Activation As Well As IL-6 Gene Expression

Activation of Ikk by Tnf Alpha Requires Site-Specific Ubiquitination of Rip1 and Polyubiquitin Binding by Nemo

Poly(I-C)-induced Toll-like Receptor 3 (Tlr3)-Mediated Activation of NFκB and MAP Kinase is Through an Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing the Signaling Components TLR3-TRAF6-TAK1-TAB2-PKR

IκB Kinase is an Essential Component of the Tpl2 Signaling Pathway

The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes.

IRAK4 Kinase Activity is Redundant for Interleukin-1 (IL-1) Receptor-associated Kinase Phosphorylation and IL-1 Responsiveness

Transforming growth factor (TGF)-β-activated kinase 1 (TAK1) activation requires phosphorylation of serine 412 by protein kinase A catalytic subunit α (PKACα) and X-linked protein kinase (PRKX)

Direct Activation of Protein Kinases by Unanchored Polyubiquitin Chains

Lysine 63-Linked Polyubiquitination of TAK1 at Lysine 158 is Required for Tumor Necrosis Factor Α- and Interleukin-1β-induced IKK/NF-κB and JNK/AP-1 Activation

Poly(Di Center Dot Dc)-Induced Toll-Like Receptor 3 (Tlr3)-Mediated Activation Of Nf Kappa B And Map Kinase Is Through An Interleukin-1 Receptor-Associated Kinase (Irak)-Independent Pathway Employing The Signaling Components Tlr3-Traf6-Tak1-Tab2-Pkr

Activation of the Heterodimeric IκB Kinase α (IKKα)-IKKβ Complex Is Directional: IKKα Regulates IKKβ under Both Basal and Stimulated Conditions

TAK1 is Recruited to the Tumor Necrosis Factor-α (Tnf-Α) Receptor 1 Complex in a Receptor-interacting Protein (Rip)-Dependent Manner and Cooperates with MEKK3 Leading to NF-κB Activation*

Functional Involvement of TANK‐Binding Kinase 1 in the MyD88‐Dependent NF‐ κ B Pathway Through Syk